ORI: Researcher Faked Dozens of Experiments

A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Western blotWIKIMEDIA, TIMVICKERS“All told, [Ricky] Malhotra claimed to have conducted 74 experiments that never happened, and falsified well over 100 Western blots,” Retraction Watch reported today (May 25). The former University of Michigan and University of Chicago researcher admitted to the misconduct, which over the course of six years involved three National Institutes of Health (NIH) grant applications and a 2010 manuscript published in the Journal of Biological Chemistry, according to a case summary published this week (May 24) by the Office of Research Integrity (ORI). The agency noted that Malhotra has agreed to retract the JBC paper.

According to his LinkedIn profile, Malhotra worked at an Ann Arbor, Michigan–based microscopy company called PicoCal and is now serving as cardiovascular and metabolic consultant in the greater Boston area. He told the ORI that he does not plan to apply for any US Public Health Service funding. If he should do so in the next five years, his work will be supervised and he will be required to provide biannual reports to verify the legitimacy of his research, according to the ORI summary.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio